Andrew Hendifar

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Andrew Hendifar

Nov 19, 2024, 20:48 | Insight

Jun Gong: ctDNA-guided adjuvant immunotherapy in stage III MSI-H dMMR colon cancer

Jun Gong, Medical Oncologist and Researcher at Cedars-Sinai Medical Center, shared a post on X…

Aug 21, 2024, 14:12 | Blog

Cedars-Sinai's 13th Annual New Therapeutics Symposium

Jun Gong, Medical oncologist and researcher in gastrointestinal and genitourinary cancers at Cedars-Sinai, shared a post…

Aug 20, 2024, 08:33 | Blog

Jun Gong: Join Cedars - Sinai 13th Annual New Therapeutics Symposium

Jun Gong, Medical Oncologist and Researcher in Gastrointestinal and Genitourinary cancers at Cedars-Sinai, shared on X:…

May 23, 2024, 11:09 | Blog

Jun Gong: The role of primary tumor resection in metastatic well-differentiated GETNET

Jun Gong, Medical Oncologist and Researcher in Gastrointestinal and Genitourinary cancers at Cedars-Sinai, shared a…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023